Home › NDC Lookup › RxCUI directory › RxCUI 809819

2.7 ML atropine 0.778 MG/ML / pralidoxime chloride 222 MG/ML Auto-Injector [Duodote] — RxCUI 809819

Name: 2.7 ML atropine 0.778 MG/ML / pralidoxime chloride 222 MG/ML Auto-Injector [Duodote] (RxCUI 809819)
Creator: Brian Staiger, PharmD

RxNorm drug concept · Semantic branded drug

RxCUI 809819 Semantic branded drug · SBD ● Current RxNorm concept 1 FDA product 1 package NDC Snapshot Jul 14, 2026

This page is curated, coded, and maintained by Dr. Brian Staiger, PharmD

Compiled from public NLM RxNorm and FDA (openFDA NDC directory) data sources. Editorial policy

What you’re looking at: the standardized identity of one medicine, as the U.S. drug-data system sees it. Below — every FDA-listed product, package code, price benchmark, and billing code that maps to it.

🗂️ Key Facts

RxCUI809819

Official name2.7 ML atropine 0.778 MG/ML / pralidoxime chloride 222 MG/ML Auto-Injector [Duodote]

Concept typeSemantic branded drug (SBD)

RxNorm statusCurrent RxNorm concept

Also known asDuodote (atropine 2.1 MG / pralidoxime chloride 600 MG) Auto-Injector; DuoDote (atropine 2.1 MG / pralidoxime Cl 600 MG) Auto-Injector

FDA products mapped1

Package NDCs mapped1

RxNorm release07/06/2026

Snapshot dataJul 14, 2026

📖 Skip the Codes — Read It in Plain English.

Our pharmacist-built guide to Atropine Ophthalmic: what it is, how it’s used, side effects, and interactions.

📗 Our plain-language guide HelloPharmacist

That's completely expected with atropine — it's actually doing its job. The drop temporarily shuts down the muscle that controls your pupil and your eye's ability to focus, and tho...
Why does my vision stay blurry and my eyes stay sensitive to light for so long after using these drops?
Good question! When one eye is significantly stronger than the other, the brain tends to ignore the weaker eye. Putting an atropine drop in the stronger eye blurs it on purpose, so...
My child's doctor prescribed these drops for lazy eye — how does that work?

📖 Read our full Atropine Ophthalmic guide →

🕸️ Concept Web — How 2.7 ML atropine 0.778 MG/ML / pralidoxime chlori... Connects

One RxCUI never lives alone. Follow the path from the raw ingredient down to the exact strength-and-form concepts FDA products carry — every stop is a real RxNorm concept with its own identifier. Hover or focus any chip for what it means.

This page's concept 2.7 ML atropine 0.778 MG/ML / pralidoxime chloride 222 MG/ML Auto-Injector [Duodote] RxCUI 809819 Semantic branded drug · SBD

Every web starts here: one RxCUI, one fixed meaning in the RxNorm vocabulary.

Ingredients 4

The active substance itself — no strength, form, or brand attached yet.
- Atropine 1223 IN
- Pralidoxime 34345 IN
- Atropine / pralidoxime 465370 MIN
- Pralidoxime chloride 55322 PIN
Brand names 1

The same medicine's trade names. A brand name alone says nothing about strength or form.
- Duodote 717229 BN
Dose forms 9

The ingredient poured into a form — tablet, solution, cream — still without one fixed strength.
- Atropine / pralidoxime Auto-Injector 1659108 SCDF
- Atropine / pralidoxime chloride Auto-Injector 2647596 SCDFP
- Atropine / pralidoxime Injectable Product 1154985 SCDG
- Atropine / pralidoxime chloride Injectable Product 2659267 SCDGP
- Atropine / pralidoxime Auto-Injector [Duodote] 1659111 SBDF
- Atropine / pralidoxime chloride Auto-Injector [Duodote] 2655579 SBDFP
- Duodote Injectable Product 1166999 SBDG
- Auto-Injector 1649570 DF
- +1 more in this family
Clinical & branded drugs 4

Ingredient + strength + dose form. These are the concepts real FDA products actually carry.
- 2.7 ML atropine 0.778 MG/ML / pralidoxime chloride 222 MG/ML Auto-Injector 727415 SCD
- Atropine 0.778 MG/ML 1664972 SCDC
- Pralidoxime chloride 222 MG/ML 1663723 SCDC
- Atropine 0.778 MG/ML / pralidoxime chloride 222 MG/ML [Duodote] 1666956 SBDC

Showing up to 8 concepts per family — 17 of 18 stored related concepts drawn.

These are official RxNorm vocabulary relationships — how concepts name and organize the same medicine. They do not establish therapeutic equivalence or substitutability: two concepts appearing in one web is never a statement that products can be swapped.

🔀 Generic ⇄ Brand Crosswalk

The same medicine has an unbranded (generic) identity and one or more brand-name identities — each with its own RxCUI. This is a naming relationship in RxNorm, not a statement that any two products are substitutable.

Generic (Clinical) Concepts

2.7 ML atropine 0.778 MG/ML / pralidoxime chloride 222 MG/ML Auto-Injector SCD · 727415
Atropine 0.778 MG/ML SCDC · 1664972
Pralidoxime chloride 222 MG/ML SCDC · 1663723
Atropine / pralidoxime Auto-Injector SCDF · 1659108
Atropine / pralidoxime chloride Auto-Injector SCDFP · 2647596
Atropine / pralidoxime Injectable Product SCDG · 1154985
Atropine / pralidoxime chloride Injectable Product SCDGP · 2659267

Brand-Name Concepts

Atropine 0.778 MG/ML / pralidoxime chloride 222 MG/ML [Duodote] SBDC · 1666956
Atropine / pralidoxime Auto-Injector [Duodote] SBDF · 1659111
Atropine / pralidoxime chloride Auto-Injector [Duodote] SBDFP · 2655579
Duodote Injectable Product SBDG · 1166999
Duodote BN · 717229

📦 FDA Products & Package NDCs

1 product · 1 package NDC

1 package NDC map to RxCUI 809819 in the current snapshot — up to 50 per page. Each linked NDC opens its full package page.

Package NDC	Package	Brand / generic name	Labeler	Marketing start
11704-0620-01	1 KIT in 1 CARTON (11704-620-01) * 1 POUCH in 1 CARTON / 1...	DuoDote	Meridian Medical Technologies LLC	2006-09-28

Observed labelers: Meridian Medical Technologies LLC (1) — this is the FDA-listed mapping footprint, not sales, inventory, availability, or market share.

🗃️ Sources & Limits

Atlas generation902fddb9-e9c1-4004-bf4c-dba4d51037c7

openFDA export observedJul 14, 2026

RxNorm release07/06/2026

Methodology2026-07-full-catalog-v1

A shared RxCUI does not prove interchangeability. Products mapped to the same concept are not thereby equivalent or substitutable — equivalence is a separate, product-level determination.
Listing here does not establish approval or coverage. Appearing in this snapshot is a data observation, not an FDA approval status or a payer coverage decision.
Missing data never means zero. A silent dataset (no price, no billing code, no utilization) means no observation — not that the real-world value is zero.
Counts describe the mapping footprint. Product, package, and labeler counts are the FDA-listed mapping footprint in this snapshot — not sales, inventory, availability, or market share.

This product uses publicly available data from the U.S. National Library of Medicine (NLM), National Institutes of Health, Department of Health and Human Services; NLM is not responsible for the product and does not endorse or recommend this or any other product.

Machine-readable JSON

Reference information about drug-concept identifiers and public regulatory data — not medical advice. Talk to your pharmacist or prescriber about your own medication.